Song WJ, Seshadri M, Ashraf U, Mdluli T, Mondal P, Keil M, Azevedo M, Kirschner LS, Stratakis CA, and Hussain MA
Participants ( n = 13) were treated with semaglutide or liraglutide in addition to standard body weight management, while a control group ( n = 26) received standard body weight management
Opt for healthy unsaturated fats (e.g., olive oil, avocado, fatty fish), which slow digestion and may enhance GLP-1 release
Designing the release curve to start low and gradually increase (mimicking the dose escalation patients usually experience with weekly GLP-1s) is crucial to avoid overwhelming patients with side effects on the first dose
Hunt B, Hansen BB, Ericsson , Kallenbach K, Ali SN, Dang-Tan T, et al
It is not medical advice, does not recommend any unapproved drug, and does not provide dosing or treatment guidance